Boston Scientific Corporation develops, manufactures, and markets medical devices for interventional medical procedures worldwide. It operates through two primary segments: MedSurg, encompassing Endos... Boston Scientific Corporation develops, manufactures, and markets medical devices for interventional medical procedures worldwide. It operates through two primary segments: MedSurg, encompassing Endoscopy, Urology, and Neuromodulation; and Cardiovascular, including Cardiology and Peripheral Interventions. The company provides innovative solutions such as resolution clips, biliary stent systems, stents, electrocautery enhanced delivery systems, direct visualization systems, digital catheters, single-use duodenoscopes, endoluminal surgery tools, and infection prevention products for gastrointestinal conditions. Its portfolio also features less invasive devices for angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal diagnostics, interventional oncology, neuromodulation for chronic pain, and incontinence treatment. Boston Scientific Corporation serves healthcare professionals and institutions globally, with foreign sales forming a significant portion of its business, focusing on minimally invasive therapies across cardiology, endoscopy, urology, and neuromodulation sectors. Founded in 1979 and headquartered in Marlborough, Massachusetts, it plays a vital role in advancing medical device innovation for improved patient outcomes in interventional specialties.
Boston Scientific is not subject to EU Taxonomy reporting
Based on current regulatory requirements, Boston Scientific is not required to report EU
Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU
Taxonomy data review for this company.
If you believe this assessment should be revisited, you may submit a data coverage request
and our team will review the company's regulatory applicability.